Who owns NOVABAY PHARMACEUTICALS INC?
- Ticker: NBY
- CUSIP Number: 66987p409
Tip: Access positions for across all investors
Analyze quarterly positions in Novabay Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Novabay Pharmaceuticals stock
Who bought or sold NOVABAY PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| C2C Wealth Management | 43k | $31k | 100% | Sep 2024 |
|
| Geode Capital Management | 26k | $18k | 100% | Sep 2024 |
|
| UBS Group | 21k | $15k | 158% | Sep 2024 |
|
| Virtu Financial | 20k | $13k | 100% | Sep 2024 |
|
| Warberg Asset Management | 10k | $6.9k | 100% | Sep 2024 |
|
| Tower Research Capital | 5.5k | $3.8k | 66% | Sep 2024 |
|
| Bank of America Corporation | 42.00 | $29.001000 | 0% | Sep 2024 |
|
| NVWM | 3.00 | $2.000100 | 0% | Dec 2024 |
|
| Ronald Blue Trust | 2.00 | $1.000000 | 0% | Dec 2024 |
|
| Northwestern Mutual Wealth Management Company | 1.00 | $1.000000 | 0% | Sep 2024 |
|
| Royal Bank of Canada | 1.00 | $0 | 0% | Sep 2024 |
|
| Addison Advisors | 1.00 | $1.000000 | 0% | Sep 2024 |
|